INAB

IN8bio (INAB)

IN8bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:INAB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/12/10	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/12/10	21:00	GlobeNewswire Inc.	IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/12/02	21:00	GlobeNewswire Inc.	IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference	NASDAQ:INAB	IN8bio Inc
2024/11/25	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/11/25	21:00	GlobeNewswire Inc.	IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/11/13	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:INAB	IN8bio Inc
2024/11/13	06:45	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:INAB	IN8bio Inc
2024/11/13	06:33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INAB	IN8bio Inc
2024/11/13	06:26	GlobeNewswire Inc.	IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:INAB	IN8bio Inc
2024/11/12	21:00	GlobeNewswire Inc.	IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/11/05	23:00	GlobeNewswire Inc.	IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/11/05	06:31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:INAB	IN8bio Inc
2024/10/16	05:04	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:INAB	IN8bio Inc
2024/10/12	07:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/10/09	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/10/09	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/10/09	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/10/02	05:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/10/01	21:00	GlobeNewswire Inc.	IN8bio Announces Pricing of $12.4 Million Private Placement	NASDAQ:INAB	IN8bio Inc
2024/09/12	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/09/07	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/09/06	05:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc